SLC18A3 and Alzheimer disease: Changes in presynaptic cholinergic functions, such as ChAT and VAChT activity in AD, are thought to be more significant than changes in postsynaptic cholinergic functions, such as the cholinergic muscarinic receptors (mAChR) [26, 27, 32].